2017 Q4 Form 10-Q Financial Statement

#000119312517338765 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q3
Revenue $21.60M $24.04M $17.85M
YoY Change 1.89% 34.73% 9.92%
Cost Of Revenue $1.920M $1.726M $1.422M
YoY Change 17.79% 21.38% 11.01%
Gross Profit $19.68M $22.32M $16.42M
YoY Change 0.61% 35.89% 9.83%
Gross Profit Margin 91.11% 92.82% 92.03%
Selling, General & Admin $6.250M $5.768M $4.981M
YoY Change 16.6% 15.8% 9.07%
% of Gross Profit 31.76% 25.84% 30.33%
Research & Development $9.970M $10.03M $7.346M
YoY Change 28.31% 36.55% 11.79%
% of Gross Profit 50.66% 44.95% 44.73%
Depreciation & Amortization $870.0K $840.0K $700.0K
YoY Change 22.54% 20.0% 20.69%
% of Gross Profit 4.42% 3.76% 4.26%
Operating Expenses $16.53M $16.11M $12.64M
YoY Change 22.99% 27.48% 10.23%
Operating Profit $3.150M $6.210M $3.788M
YoY Change -48.53% 63.94% 8.51%
Interest Expense $880.0K $820.0K $620.0K
YoY Change 109.52% 32.26% 55.0%
% of Operating Profit 27.94% 13.2% 16.37%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $4.030M $7.031M $4.403M
YoY Change -38.47% 59.69% 13.13%
Income Tax $860.0K $1.181M $1.015M
% Of Pretax Income 21.34% 16.8% 23.05%
Net Earnings $3.160M $5.850M $3.388M
YoY Change -39.23% 72.67% 2.39%
Net Earnings / Revenue 14.63% 24.33% 18.98%
Basic Earnings Per Share $0.27 $0.16
Diluted Earnings Per Share $138.6K $0.26 $0.15
COMMON SHARES
Basic Shares Outstanding 21.97M shares 21.95M shares 21.03M shares
Diluted Shares Outstanding 22.68M shares 21.88M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.4M $97.39M $78.93M
YoY Change 30.07% 23.39% -5.02%
Cash & Equivalents $21.74M $22.93M $20.00M
Short-Term Investments $82.66M $74.46M $58.93M
Other Short-Term Assets $3.700M $4.600M $2.900M
YoY Change 19.35% 58.62% -50.85%
Inventory
Prepaid Expenses
Receivables $16.49M $12.89M $17.25M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $159.1M $155.8M $140.1M
YoY Change 9.93% 11.25% 42.79%
LONG-TERM ASSETS
Property, Plant & Equipment $6.926M $6.698M $4.831M
YoY Change 44.14% 38.65% 61.36%
Goodwill $46.61M $46.61M $46.61M
YoY Change 0.0% 0.0% 0.0%
Intangibles $3.287M
YoY Change -27.57%
Long-Term Investments $49.90M $43.80M $29.50M
YoY Change 50.3% 48.47% -38.67%
Other Assets $3.579M $4.588M $4.358M
YoY Change 153.47% 5.28% 141.31%
Total Long-Term Assets $117.7M $111.3M $94.41M
YoY Change 20.41% 17.94% -14.26%
TOTAL ASSETS
Total Short-Term Assets $159.1M $155.8M $140.1M
Total Long-Term Assets $117.7M $111.3M $94.41M
Total Assets $276.8M $267.2M $234.5M
YoY Change 14.15% 13.94% 12.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $500.0K $1.100M
YoY Change -33.33% -54.55% 22.22%
Accrued Expenses $3.927M $3.070M $4.490M
YoY Change -2.19% -31.63% 39.01%
Deferred Revenue $4.399M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.80M $18.47M $21.28M
YoY Change 0.89% -13.21% 29.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.300M $9.800M $8.500M
YoY Change 12.05% 15.29% 13.33%
Total Long-Term Liabilities $9.300M $9.800M $8.500M
YoY Change 12.05% 15.29% 13.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.80M $18.47M $21.28M
Total Long-Term Liabilities $9.300M $9.800M $8.500M
Total Liabilities $32.10M $28.20M $29.80M
YoY Change 3.88% -5.37% 19.2%
SHAREHOLDERS EQUITY
Retained Earnings $53.87M $51.24M $34.49M
YoY Change 36.63% 48.54% 39.76%
Common Stock $217.4M $215.6M $210.5M
YoY Change 2.51% 2.38% -0.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $26.06M $27.63M $40.39M
YoY Change -34.05% -31.59% -24.44%
Treasury Stock Shares $1.531M 1.624M shares 2.374M shares
Shareholders Equity $244.7M $239.0M $204.7M
YoY Change
Total Liabilities & Shareholders Equity $276.8M $267.2M $234.5M
YoY Change 14.15% 13.94% 12.62%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $3.160M $5.850M $3.388M
YoY Change -39.23% 72.67% 2.39%
Depreciation, Depletion And Amortization $870.0K $840.0K $700.0K
YoY Change 22.54% 20.0% 20.69%
Cash From Operating Activities $6.770M $7.150M $3.270M
YoY Change -45.8% 118.65% -40.55%
INVESTING ACTIVITIES
Capital Expenditures -$800.0K -$1.060M -$1.290M
YoY Change 122.22% -17.83% 207.14%
Acquisitions
YoY Change
Other Investing Activities -$7.770M -$1.440M -$6.270M
YoY Change -45.36% -77.03% -720.79%
Cash From Investing Activities -$8.570M -$2.500M -$7.560M
YoY Change -41.22% -66.93% -1381.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 590.0K 1.160M 5.610M
YoY Change -4.84% -79.32% -403.24%
NET CHANGE
Cash From Operating Activities 6.770M 7.150M 3.270M
Cash From Investing Activities -8.570M -2.500M -7.560M
Cash From Financing Activities 590.0K 1.160M 5.610M
Net Change In Cash -1.210M 5.810M 1.320M
YoY Change -17.69% 340.15% -68.87%
FREE CASH FLOW
Cash From Operating Activities $6.770M $7.150M $3.270M
Capital Expenditures -$800.0K -$1.060M -$1.290M
Free Cash Flow $7.570M $8.210M $4.560M
YoY Change -41.09% 80.04% -22.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21974975 shares
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19998000
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1623813 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21971347 shares
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23595160 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
311056 shares
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51235000
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
267175000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10655000
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4274000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-201000
CY2017Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
468000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
238956000
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
22000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
215532000
CY2017Q3 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
9752000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18467000
CY2017Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
104000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3070000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
155829000
CY2017Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
328000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
62188000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
37050000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
89000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6698000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22931000
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2940000
CY2017Q3 us-gaap Goodwill
Goodwill
46612000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4588000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4588000
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
27632000
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingAggregateIntrinsicValue
19598000
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageExercisePrice
19.18
CY2017Q3 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
323000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12885000
CY2017Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
111346000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
61956000
CY2017Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
74459000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
239000
CY2017Q3 us-gaap Assets
Assets
267175000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
8997000
CY2017Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
74683000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
12495000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
12503000
CY2017Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
0
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2051000
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableNumber
604327 shares
CY2017Q3 ceva Available For Sale Matures Within One Year Gross Unrealized Loss
AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss
5000
CY2017Q3 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
91000
CY2017Q3 ceva Long Term Bank Deposits
LongTermBankDeposits
39214000
CY2017Q3 ceva Available For Sale Matures Within One Year Gross Unrealized Gains
AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
13000
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageExercisePrice
19.81
CY2017Q3 ceva Accrued Severance Pay Noncurrent
AccruedSeverancePayNoncurrent
9752000
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
852587 shares
CY2017Q3 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableAggregateIntrinsicValue
14271000
CY2017Q3 ceva Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
9243000
CY2017Q3 ceva Short Term Bank Deposits
ShortTermBankDeposits
40966000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18909000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2321660 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21273500 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23595160 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39431000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
242495000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11751000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6258000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-497000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
571000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
211551000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
212103000
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
8349000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22595000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4015000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
144712000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
586000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
52991000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
48663000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
29000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4805000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18401000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2252000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15044000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
97783000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
52423000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
61868000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
557000
CY2016Q4 us-gaap Assets
Assets
242495000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
4875000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
62447000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
9456000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
9445000
CY2016Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
6000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2978000
CY2016Q4 us-gaap Goodwill
Goodwill
46612000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3218000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3152000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39507000
CY2016Q4 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss
571000
CY2016Q4 ceva Available For Sale Matures Within One Year Gross Unrealized Loss
AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss
15000
CY2016Q4 ceva Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains
AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains
3000
CY2016Q4 ceva Long Term Bank Deposits
LongTermBankDeposits
29977000
CY2016Q4 ceva Available For Sale Matures Within One Year Gross Unrealized Gains
AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
4000
CY2016Q4 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageExercisePrice
19.76
CY2016Q4 ceva Accrued Severance Pay Noncurrent
AccruedSeverancePayNoncurrent
8349000
CY2016Q4 ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber
1455908 shares
CY2016Q4 ceva Severance Pay Fund Noncurrent
SeverancePayFundNoncurrent
7941000
CY2016Q4 ceva Short Term Bank Deposits
ShortTermBankDeposits
46247000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39856 shares
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> <b>NOTE 12: IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS NOT YET ADOPTED</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td width="13%">&#xA0;</td> <td valign="top" width="4%" align="left"><b>(a)</b></td> <td valign="top" align="left"><b>Revenue recognition</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In May 2014, the FASB issued a new standard related to revenue recognition. Under the new standard, revenue is recognized when a customer obtains control of promised goods or services and is recognized in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The FASB has recently issued several amendments to the standard, including clarification on identifying performance obligations.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The guidance permits two methods of modification: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative&#xA0;<font style="WHITE-SPACE: nowrap">catch-up</font>&#xA0;transition method). The Company currently anticipates adopting the standard using the modified retrospective method rather than full retrospective method.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The new standard will be effective for the Company beginning on January&#xA0;1, 2018, but adoption as of the original effective date of January&#xA0;1, 2017 is permitted. The Company will adopt the new standard as of January&#xA0;1, 2018.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The Company has made progress toward completing its evaluation of the potential changes from adopting this new standard on its financial reporting and disclosures. The Company has evaluated the impact of the standard on a majority of its revenue streams and associated contracts. The Company will complete the contract evaluations and validate the results throughout 2017. The Company formed an implementation work group and expects to complete the evaluation of the impact of the accounting and disclosure changes on its business processes, controls and systems throughout 2017, design any changes to such business processes, controls and systems, and implement the changes before the end of 2017.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Under the new standard, an entity recognizes revenue when or as it satisfies a performance obligation by transferring IP license or services to the customer, either at a point in time or over time. The Company expects to continue to recognize most of its revenue at a point in time upon delivery of its products. The Company expects to recognize revenue over time on significant license customization contracts that are covered by contract accounting standards using cost inputs to measure progress toward completion of its performance obligations, which is similar to the current method.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> Based on its current analysis, the most significant effect on the Company, if any, will be related to certain deliverables that may be considered as distinct performance obligations separate from other performance obligations and will be measured using the relative standalone selling price basis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In addition, incremental costs that are related to sales from contracts signed during the period would require capitalization. The Company also will consider if there is a significant financing component if the time between payment and performance is more than one year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> The Company continues to assess all potential impacts under the new revenues standard.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6px; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; ORPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="break-inside: avoid"> <td width="13%">&#xA0;</td> <td valign="top" width="4%" align="left"><b>(b)</b></td> <td valign="top" align="left"><b>Other accounting standard</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 8%; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"> In February 2016, the FASB issued ASU&#xA0;<font style="WHITE-SPACE: nowrap">2016-02,</font>&#xA0;&#x201C;Leases (Topic 842),&#x201D; which will replace the existing guidance in ASC 840, &#x201C;Leases.&#x201D; The updated standard aims to increase transparency and comparability among organizations by requiring lessees to recognize lease assets and lease liabilities on the balance sheet and requiring disclosure of key information about leasing arrangements. This ASU is effective for annual periods beginning after December&#xA0;15, 2018, and interim periods within those annual periods; early adoption is permitted and modified retrospective application is required. The Company is in the process of evaluating this guidance to determine the impact it will have on its financial statements and related disclosures.</p> </div>
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
dei Entity Central Index Key
EntityCentralIndexKey
0001173489
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>NOTE 1: BUSINESS</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The financial information in this quarterly report includes the results of CEVA, Inc. and its subsidiaries (the &#x201C;Company&#x201D; or &#x201C;CEVA&#x201D;).</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> CEVA licenses a family of signal processing IPs, including programmable DSP cores and application-specific platforms for advanced imaging, computer vision and deep learning for many camera-enabled devices, sound, voice and audio, as well as long and short range wireless technologies for <font style="WHITE-SPACE: nowrap">LTE/LTE-A/5G</font> baseband processing in handsets and infrastructure, short range wireless for <font style="WHITE-SPACE: nowrap">Wi-Fi</font> and Bluetooth IPs, wired interface for storage, Serial ATA (SATA) and Serial Attached SCSI (SAS).</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> CEVA&#x2019;s technologies are licensed to leading semiconductor and original equipment manufacturer (OEM) companies in the form of intellectual property (IP). These companies design, manufacture, market and sell application-specific integrated circuits (&#x201C;ASICs&#x201D;) and application-specific standard products (&#x201C;ASSPs&#x201D;) based on CEVA&#x2019;s technology to wireless, consumer electronics and automotive companies for incorporation into a wide variety of end products.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17698000
dei Trading Symbol
TradingSymbol
CEVA
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22480000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21687000 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
793000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"> <i>Use of Estimates</i></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company&#x2019;s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the interim condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
dei Entity Registrant Name
EntityRegistrantName
CEVA INC
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Revenues
Revenues
65906000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3340000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
355000
us-gaap Investment Income Net
InvestmentIncomeNet
2147000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-33000
us-gaap Operating Income Loss
OperatingIncomeLoss
12726000
us-gaap Net Income Loss
NetIncomeLoss
13865000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2159000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14161000
us-gaap Royalty Revenue
RoyaltyRevenue
32013000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
36468000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
322000
us-gaap Licenses Revenue
LicensesRevenue
33893000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3934000
us-gaap Gross Profit
GrossProfit
60876000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
24000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
180000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
296000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
349000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
-6000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2572000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14873000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
14000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6346000
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
47000
us-gaap Depreciation
Depreciation
1447000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
157000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1008000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-105000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-20223000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6898000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
15206000
ceva Investment In Bank Deposits
InvestmentInBankDeposits
30757000
us-gaap Share Based Compensation
ShareBasedCompensation
6346000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1984000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9422000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7388000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
416000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6898000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30413000
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
3003000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
927000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4530000
us-gaap Cost Of Revenue
CostOfRevenue
5030000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1501000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
907000
us-gaap Operating Expenses
OperatingExpenses
48150000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-33000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
186000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
53000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
8086000
ceva Increase Decrease In Deferred Tax Net
IncreaseDecreaseInDeferredTaxNet
-741000
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerms
P4Y8M12D
ceva Increase Decrease In Accrued Interest On Bank Deposits
IncreaseDecreaseInAccruedInterestOnBankDeposits
3000
ceva Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
60000
ceva Share Based Compensation Arrangements By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice
19.74
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresInPeriod
14349 shares
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriod
588972 shares
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grant In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantInPeriodWeightedAverageExercisePrice
0
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod
0 shares
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
17.56
ceva Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerms
P5Y2M12D
ceva Proceeds From Bank Deposits
ProceedsFromBankDeposits
27050000
ceva Increase Decrease In Accrued Salaries And Related Expenses
IncreaseDecreaseInAccruedSalariesAndRelatedExpenses
1532000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
180013 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
18.98
ceva Treasury Stock Value Acquired Weighted Average Method
TreasuryStockValueAcquiredWeightedAverageMethod
3417000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
349428 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1966000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21395000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20718000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
677000 shares
us-gaap Revenues
Revenues
51457000
us-gaap Investment Income Net
InvestmentIncomeNet
1617000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
32498000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
492000
us-gaap Licenses Revenue
LicensesRevenue
23576000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1604000
us-gaap Gross Profit
GrossProfit
47004000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
29000
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
218000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
452000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2031000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3417000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
508000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-16000
us-gaap Operating Income Loss
OperatingIncomeLoss
8257000
us-gaap Net Income Loss
NetIncomeLoss
7899000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13172000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8351000
us-gaap Royalty Revenue
RoyaltyRevenue
27881000
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
535000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
27000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1403000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9874000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
67000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
16000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4648000
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
32000
us-gaap Depreciation
Depreciation
998000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1975000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
370000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6447000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8998000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
14253000
us-gaap Share Based Compensation
ShareBasedCompensation
4648000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1269000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8463000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6286000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-62000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5581000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23071000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
927000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1089000
us-gaap Cost Of Revenue
CostOfRevenue
4453000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
894000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
757000
us-gaap Operating Expenses
OperatingExpenses
38747000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-16000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
191000
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
83000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7316000
ceva Investment In Bank Deposits
InvestmentInBankDeposits
19100000
ceva Increase Decrease In Deferred Tax Net
IncreaseDecreaseInDeferredTaxNet
-571000
ceva Increase Decrease In Accrued Interest On Bank Deposits
IncreaseDecreaseInAccruedInterestOnBankDeposits
395000
ceva Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
176000
ceva Proceeds From Bank Deposits
ProceedsFromBankDeposits
25613000
ceva Increase Decrease In Accrued Salaries And Related Expenses
IncreaseDecreaseInAccruedSalariesAndRelatedExpenses
356000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
92103 shares
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21883000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21025000 shares
CY2016Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
858000 shares
CY2016Q3 us-gaap Revenues
Revenues
17846000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
46000
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
615000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3788000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
3388000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3427000
CY2016Q3 us-gaap Royalty Revenue
RoyaltyRevenue
10390000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
46000
CY2016Q3 us-gaap Licenses Revenue
LicensesRevenue
7456000
CY2016Q3 us-gaap Gross Profit
GrossProfit
16424000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
75000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
39000
CY2016Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
52000
CY2016Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax
6000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4403000
CY2016Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1565000
CY2016Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
1000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1015000
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2763000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2218000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7346000
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
1422000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
12636000
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
69000
CY2016Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
13000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22683000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21946000 shares
CY2017Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
737000 shares
CY2017Q3 us-gaap Revenues
Revenues
24044000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
89000
CY2017Q3 us-gaap Investment Income Net
InvestmentIncomeNet
821000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6210000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
5850000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5927000
CY2017Q3 us-gaap Royalty Revenue
RoyaltyRevenue
10023000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
96000
CY2017Q3 us-gaap Licenses Revenue
LicensesRevenue
14021000
CY2017Q3 us-gaap Gross Profit
GrossProfit
22318000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-2000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
77000
CY2017Q3 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
89000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7031000
CY2017Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
8000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2219000
CY2017Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
1000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1181000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3057000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2711000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10031000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
309000
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
1726000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
16108000
CY2017Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
7000
CY2017Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-2000
CY2017Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
12000

Files In Submission

Name View Source Status
0001193125-17-338765-index-headers.html Edgar Link pending
0001193125-17-338765-index.html Edgar Link pending
0001193125-17-338765.txt Edgar Link pending
0001193125-17-338765-xbrl.zip Edgar Link pending
ceva-20170930.xml Edgar Link completed
ceva-20170930.xsd Edgar Link pending
ceva-20170930_cal.xml Edgar Link unprocessable
ceva-20170930_def.xml Edgar Link unprocessable
ceva-20170930_lab.xml Edgar Link unprocessable
ceva-20170930_pre.xml Edgar Link unprocessable
d479740d10q.htm Edgar Link pending
d479740dex311.htm Edgar Link pending
d479740dex312.htm Edgar Link pending
d479740dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending